Tumor recurrence and drug resistance properties of side population cells in high grade ovary cancer

Drug Research

Volumn 65, Issue 3, 2015, Pages 153-157

  Zhang, Q H ^a,b   Dou, H T ^b   Xu, P ^c   Zhuang, S C ^b   Liu, P S ^a  

^a SHANDONG UNIVERSITY   (China)

^b Central Hospital of Zibo   (China)

^c People's Hospital of Zhangqiu   (China)

Author keywords

apoptosis; cancer stem cells; chemotherapy; side population cells; tumor recurrence

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; EPITHELIAL CELL ADHESION MOLECULE; HERMES ANTIGEN; HOE 33342; MEMBRANE PROTEIN; PROTEIN BCL 2; VASCULAR ENDOTHELIAL CADHERIN; VERAPAMIL; ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; CADHERIN; CD44 PROTEIN, HUMAN; CELL ADHESION MOLECULE; EPCAM PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; TUMOR ANTIGEN; TUMOR PROTEIN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RECURRENCE; CANCER RESISTANCE; CANCER STEM CELL; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; OVARY CANCER; PREVALENCE; PROTEIN EXPRESSION; SIDE POPULATION CELL; SURVIVAL RATE; WESTERN BLOTTING; DRUG EFFECTS; DRUG RESISTANCE; METABOLISM; OVARIAN NEOPLASMS; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR RECURRENCE;

ANTIGENS, CD; ANTIGENS, CD44; ANTIGENS, NEOPLASM; ATP-BINDING CASSETTE TRANSPORTERS; CADHERINS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIDE-POPULATION CELLS; VERAPAMIL;

EID: 84924361195     PISSN: 21949379     EISSN: 21949387     Source Type: Journal    
DOI: 10.1055/s-0034-1375609     Document Type: Article

References (21)

1. Lengyel E. Ovarian cancer development and metastasis. Am J Pathol: 2010; 177 1053 1064
2. Kurman R. J., Shih I. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer - shifting the paradigm. Hum Pathol: 2011; 42 918 931
3. Kurman R. J., Shih I. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol: 2010; 34 433 443
4. Cannistra S. A. Cancer of the ovary. N Eng J Med: 2004; 351 2519 2529
5. Ozols R. F. Treatment goals in ovarian cancer. Int J Gynecol Cancer: 2005; 15 3 11
6. Challen G. A., Little M. H. A side order of stem cells: the SP phenotype. Stem Cells: 2006; 24 3 12
7. Ramachandran C., Melnick S. J. Multidrug resistance in human tumors molecular diagnosis and clinical significance. Mol Diagn: 1999; 4 81 94
8. Ford J. M., Hait W. N. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev: 1990; 42 155 199
9. Sánchez-García I., Vicente-Dueñas C., Cobaleda C. The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice? Bioessays: 2007; 29 1269 1280
10. Kondo T., Setoguchi T., Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA: 2004; 101 781 786
11. Hirschmann-Jax C., Foster A. E., Wulf G. G. et al. A distinct side population of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad USA: 2004; 101 14228 14233
12. He Q. Z., Luo X. Z., Wang K. et al. Isolation and characterization of cancer stem cells from high-grade serous ovarian carcinomas. Cell Physiol Biochem: 2014; 33 173 184
13. Yanamoto S., Kawasaki G., Yamada S. et al. Isolation and characterization of cancer stem-like side population cells in human oral cancer cells. Oral Oncol: 2011; 47 855 860
14. Baccelli I., Trumpp A. The evolving concept of cancer and metastasis stem cells. J Cell Biol: 2012; 198 281 293
15. Clevers H. The cancer stem cell: premises, promises and challenges. Nat Med: 2011; 17 313 319
16. Patrawala L., Calhoun T., Schneider-Broussard R. et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res: 2005; 65 6207 6219
17. Robey R. W., Shukla S., Finley E. M. et al. Inhibition of Pgp (ABCB1) and MDR associated protein-1 (ABCC1) mediate transport by the orally administered inhibitor CBT-1. Biochemical Pharmacol: 2008; 75 1032 1042
18. Tirino V., Desiderio V., Paino F. et al. Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization. Faseb J: 2013; 27 13 24
19. Baba T., Convery P. A., Matsumura N. et al. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene: 2009; 28 209 218
20. Silva I. A., Bai S., McLean K. et al. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res: 2011; 71 3991 4001
21. Yanamoto S., Kawasaki G., Yoshitomi I. et al. Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy. Oral Oncol: 2007; 43 869 877